Results
Filtros
European Union may recognize hemp flower as agricultural product
Proposal from the European Commission paves the way for full regulation of hemp and strengthening of the non-psychoactive cannabis market
Germany creates the first compassionate access program to psilocybin in the European Union
Groundbreaking program approved by the German government allows clinics to treat treatment-resistant depression with psilocybin, under medical supervision and without the need for individual authorization
Public Medicinal Cannabis Clinic in Ribeirão Pires has already provided nearly 500 free consultations in six months
The unit also distributed 368 free bottles of cannabis-based oil
Fiocruz concludes R$ 4 million study on judicial actions for cannabis in Brazil
Unprecedented analysis mapped lawsuits filed against the Union for access to treatments and aims to support public policies of the Ministry of Health regarding the increasing demand in the SUS
Scientific and professional fair inspires doctors and future prescribers with innovation and welcoming atmosphere
The event brought together students and professionals who see the event as a unique opportunity for exchange, scientific updating, and connection with the future of medicine
São Paulo City Council Committee approves project guaranteeing supply of cannabidiol by SUS
PL 569/2021, which provides for the supply of cannabidiol-based medications in public and affiliated units, has a favorable opinion in the Health Committee
Brazilian universities advance in research to standardize medicinal cannabis
Project creates a phytochemical database and seeks innovative protocols to ensure safety, quality, and efficacy of cannabinoid products
Anvisa approves new cannabis-based product in Brazil
Cannten's extract with 71.33 mg/mL expands medicinal treatment options in the country and receives authorization for commercialization
Anvisa approves new pharmaceutical product based on cannabis in Brazil
Endogen's extract expands the portfolio of options for medicinal treatments and already has sanitary authorization for commercialization
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
Published by Anvisa, new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Psychedelics in Brazil: advances, challenges, and what you need to know about regulation
Recent study gathers 28 scientific articles and points out the main bioethical advances and challenges in the therapeutic use of psychedelics in Brazil, highlighting the need for regulation, safety, informed consent, and fair access to therapies
Psychedelics in Brazil: advances, challenges, and what you need to know about regulation
Recent study gathers 28 scientific articles and points out the main bioethical advances and challenges in the therapeutic use of psychedelics in Brazil, highlighting the need for regulation, safety, informed consent, and fair access to therapies
Request for cannabis-based medicine without registration at Anvisa must be judged by the Federal Justice
STJ decision reinforces federal competence for actions involving unregistered drugs at the regulatory agency
Request for cannabis-based medicine without registration at Anvisa must be judged by the Federal Court
STJ decision reinforces federal jurisdiction for actions involving unregistered drugs at the regulatory agency
France moves forward with pharmaceutical framework for medical cannabis
New regulation could make the country a reference in the sector by 2026
What to Expect for the Cannabis Industry Under Colombia's New National Drug Policy
The new National Drug Policy aims to reduce harm, address historical inequalities, and regulate the cannabis industry with a focus on social justice, sustainable development, and productive inclusion.
Basketball player Carmelo Anthony bets on cannabis to expand his impact off the court
In partnership with the indigenous cultivator Skyworld, basketball player Carmelo Anthony launches the Hall of Flame brand, combining representation, purpose, and innovation in the cannabis market
Anvisa approves new cannabis-based product in Brazil
Pharmaceutical company Ephar has obtained registration for its Cannabidiol in two concentrations, 50 mg/mL and 100 mg/mL, which will be marketed in a low THC content drop solution